Allostery Investments’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,700
Closed -$496K 44
2024
Q4
$496K Buy
+9,700
New +$496K 0.52% 22